Cytology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Interventions: Procedure: Surgical Resection; Drug: Adjuvant Atezolizumab-Bevacizumab Therapy Sponsors: National Cancer Centre, Singapore; Singapore General Hospital; National University Hospital, Singapore; Changi General Hospital; Sengkang General Hospital; Tan Tock Seng Hospital; Singapore Clinical Research Institute; Genome Institute of Singapore; I nstitute of Molecular and Cell Biology of Singapore; Cancer Science Institute of Singapore; Duke-NUS Graduate Medical School; Singapore Phenome Centre; Na...
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials

the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy
Conditions: Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology; The TNM (8th) Phase is IV; With EGFR Mutations; Meningeal Progression Occurred After Previous Platinum-containing Two-drug Chemotherapy and Third-generation EGFR-TKI Treatment; Male or Female; The Age o f 18 Years Old or More; ECOG PS 0 to 2 Points Intervention: Sponsor: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 11, 2022 Category: Research Source Type: clinical trials